Oric Pharmaceuticals Inc (ORIC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $779.47M
Last updated: Nov 17, 2026 at 4:40 PM ET
Oric Pharmaceuticals Inc (ORIC) Statistics
Oric Pharmaceuticals (ORIC) has a market cap of $779.47M and an enterprise value of $745.62M. Revenue fell 100.00% over the last 12 months from the 12 months before. Its share count is up 9.32% from a year earlier.
Total Valuation
Enterprise value is 4.34% below the market cap, as cash exceeds debt.
| Market Cap | $779.47M |
|---|---|
| Enterprise Value | $745.62M |
| Latest price (Nov 17, 2026) | $8.00 |
Key Dates
The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 16, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 34.69% over 52 weeks and trades 29.58% below its 50-day average.
| Beta (1Y) | 1.21 |
|---|---|
| 52-Week Change | -34.69% |
| 1-Month Change | -37.11% |
| 3-Month Change | -45.39% |
| 6-Month Change | +0.38% |
| 5-Year Change | -36.89% |
| Total Return (1Y) | -34.69% |
| Total Return (3Y CAGR) | +5.36% |
| Total Return (5Y CAGR) | -13.58% |
| Return vs SPY (1Y) | -44.33% |
| Max Drawdown (1Y) | -48.67% |
| Max Drawdown (3Y) | -73.46% |
| Sharpe Ratio (1Y) | -0.41 |
| Correlation with SPY (1Y) | 0.17 |
| 50-Day Average | $11.36 |
| 200-Day Average | $10.97 |
| 52-Week Range | $7.23 to $14.68 |
| RSI (14 Days) | 34.9 |
| Average Volume (20 Days) | 1.98M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 11.09x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 11.09x |
|---|---|
| Quick Ratio | 11.09x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -45.90% over the last 12 months, against a 5-year average of -40.02%.
| Return on Equity (ROE) | -45.90% |
|---|---|
| Return on Assets (ROA) | -42.48% |
| ROE (5Y Average) | -40.02% |
| ROA (5Y Average) | -36.13% |
| ROIC (5Y Average) | -29.39% |
Scores
ORIC has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$320.00K |
| Operating Income | -$171.02M |
| Pretax Income | -$155.84M |
| Net Income | -$155.84M |
| Reported EPS (TTM) | -$1.46 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 92.53% of the $366.89M in total assets.
| Cash and Equivalents | $33.85M |
|---|---|
| Total Debt | $0 |
| Net Cash | $33.85M |
| Net Cash Per Share | $0.31 |
| Working Capital | $249.97M |
| Shareholder Equity | $339.50M |
| Book Value Per Share | $3.14 |
| Total Assets | $366.89M |
| Total Liabilities | $27.38M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $692.00K of capital spending, operating cash flow left -$129.20M of free cash flow.
| Operating Cash Flow | -$128.51M |
|---|---|
| Capital Expenditures | $692.00K |
| Free Cash Flow | -$129.20M |
| FCF Per Share | -$1.25 |
| Depreciation and Amortization | $2.06M |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | +5.96% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | +5.96% |
Dividends and Yields
ORIC does not pay a dividend. Its free cash flow yield is -14.93%.
| FCF Yield | -14.93% |
|---|---|
| Buyback Yield | -7.15% |
| Shareholder Yield | -7.15% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About ORIC
What is ORIC's market cap?
Oric Pharmaceuticals has a market cap of $779.47M. Its enterprise value, which adds debt and subtracts cash, is $745.62M.
How many shares of ORIC are outstanding?
Oric Pharmaceuticals has 108.18M shares outstanding. The count is up 9.32% from a year earlier.
Does ORIC pay a dividend?
No. Oric Pharmaceuticals does not pay a dividend.
How much debt does ORIC have?
Oric Pharmaceuticals has $0 of total debt and $33.85M of cash and equivalents, a net cash position of $33.85M.
ORIC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors